36 126

Cited 0 times in

In Vitro Antimicrobial Activities of Arbekacin against Methicillin-Resistant Staphylococcus aureus

Other Title
Arbekacin의 methicillin 내성 Staphylococcus aureus에 대한 항균 효과
Authors
허, 지영; 이, 위교; 김, 활웅; 현, 봉학
Citation
Taehan Hwahak Yopŏp Hakhoe chi, 20(1):25-33, 2002
Journal Title
Taehan Hwahak Yopŏp Hakhoe chi; The journal of the Korean Society for Chemotherapy; 대한화학요법학회지
ISSN
1225-7850
Abstract
Background Arbekacin is an aminoglycoside developed in Japan and has been used since 1991 for the treatment of infections caused by methicillin-resistant Staphylococcus aureus(MRSA). The objective of this study is to determine the in vitro antimicrobial activity of arbekacin against clinical isolates of MRSA obtained from the Ajou University Hospital from March to July, 2001.

Method : The minimal inhibitory concentrations(MICs) of the 100 MRSA isolates were determined by the agar dilution method and the antimicrobial susceptibility testing was performed by the disk diffusion method. The bactericidal and the post-antibiotic effects were tested.

Results : Two isolates revealed M1Cs of 8 ug/mL, and the others < 4 ug/mL. All isolates were considered susceptible to arbekacin. Arbekacin showed concentration-dependent bactericidal activity against MRSA, and the post-antibiotic effect lasted 1.6-3.1 hours. Conclusion : These results suggest that arbekacin could provide an alternative for the treatment of MRSA
Keywords
arbekacinMRSA
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Laboratory Medicine
Full Text Link
Files in This Item:
1209005663_2001-25.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse